Correlia Biosystems is a UC Berkeley spinoff company based out of the QB3@953 startup incubator in San Francisco. Correlia develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from less than two microliters of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.